MAGENTA THERAPEUTICS INC (MGTA)
US55910K1088 - Common Stock
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 62.63M | 57.63M | 131.65M | 58.15M | 65.10M | |||
| Marketable Securities | 14.96M | 54.41M | 45.28M | 90.68M | 80.70M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 1.04M | 3.56M | 3.77M | 2.69M | 4.10M | |||
| Total Current Assets | 78.64M | 115.60M | 180.69M | 151.53M | 149.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 29.26M | 7.46M | 8.31M | 9.90M | |||
| Other Non-Current Assets | 0.00 | 1.78M | 1.78M | 1.78M | 1.80M | |||
| Total Non-Current Assets | 0.00 | 31.04M | 9.24M | 10.09M | 11.70M | |||
| TOTAL ASSETS | 78.64M | 146.65M | 189.93M | 161.62M | 161.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.22M | 12.10M | 7.27M | 7.12M | 10.70M | |||
| Accounts Payable | 813.00K | 2.45M | 3.04M | 3.76M | 2.80M | |||
| Other Current Liabilities | N/A | 0.00 | 555.00K | 555.00K | 600.00K | |||
| Total Current Liabilities | 4.03M | 14.55M | 10.86M | 11.43M | 14.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 26.14M | 6.40M | 6.28M | 6.20M | |||
| Total Non-Current Liabilities | 0.00 | 26.14M | 6.40M | 6.28M | 6.20M | |||
| TOTAL LIABILITIES | 4.03M | 40.69M | 17.26M | 17.71M | 20.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -434.48M | -402.03M | -325.57M | -254.43M | -179.50M | |||
| Additional Paid In Capital | 509.03M | 508.11M | 498.21M | 398.31M | 320.60M | |||
| Common Shares | 61.00K | 61.00K | 59.00K | 49.00K | 0.00 | |||
| Other Shareholders' Equity | -3.00K | -181.00K | -30.00K | -23.00K | 0.00 | |||
| Shares Outstanding | 3.79M | 3.79M | 3.67M | 3.03M | 39.30M | |||
| Tangible Book Value per Share | 19.68 | 27.96 | 46.99 | 47.44 | 3.59 | |||
| Total Shareholders' Equity | 74.60M | 105.96M | 172.67M | 143.91M | 141.20M | |||
| TOTAL LIABILITIES AND EQUITY | 78.64M | 146.65M | 189.93M | 161.62M | 161.50M | |||
| Statistics | ||||||||
| Current Ratio | 19.49 | 7.95 | 16.63 | 13.26 | 10.62 | |||
| Return On Assets (ROA) | -87.36% | -52.14% | -37.45% | -46.37% | -47.53% | |||
| Return On Equity (ROE) | -92.08% | -72.16% | -41.20% | -52.08% | -54.37% | |||
All data in USD